rs536725615

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_001367624.2(ZNF469):​c.8705C>T​(p.Thr2902Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00145 in 1,547,710 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T2902R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0011 ( 1 hom., cov: 34)
Exomes 𝑓: 0.0015 ( 0 hom. )

Consequence

ZNF469
NM_001367624.2 missense

Scores

1
2
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:5

Conservation

PhyloP100: -0.335

Publications

0 publications found
Variant links:
Genes affected
ZNF469 (HGNC:23216): (zinc finger protein 469) This gene encodes a zinc-finger protein. Low-percent homology to certain collagens suggests that it may function as a transcription factor or extra-nuclear regulator factor for the synthesis or organization of collagen fibers. Mutations in this gene cause brittle cornea syndrome. [provided by RefSeq, Jul 2008]
ZNF469 Gene-Disease associations (from GenCC):
  • brittle cornea syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, Genomics England PanelApp
  • brittle cornea syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • aortic disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.036779344).
BP6
Variant 16-88436175-C-T is Benign according to our data. Variant chr16-88436175-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 429662.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00109 (166/152364) while in subpopulation NFE AF = 0.00156 (106/68028). AF 95% confidence interval is 0.00132. There are 1 homozygotes in GnomAd4. There are 92 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ZNF469NM_001367624.2 linkc.8705C>T p.Thr2902Met missense_variant Exon 3 of 3 ENST00000565624.3 NP_001354553.1
ZNF469XM_047434810.1 linkc.8705C>T p.Thr2902Met missense_variant Exon 4 of 4 XP_047290766.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ZNF469ENST00000565624.3 linkc.8705C>T p.Thr2902Met missense_variant Exon 3 of 3 6 NM_001367624.2 ENSP00000456500.2 H3BS19
ZNF469ENST00000437464.1 linkc.8621C>T p.Thr2874Met missense_variant Exon 2 of 2 5 ENSP00000402343.1 Q96JG9

Frequencies

GnomAD3 genomes
AF:
0.00109
AC:
166
AN:
152246
Hom.:
1
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000386
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000523
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00301
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00156
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.000988
AC:
147
AN:
148794
AF XY:
0.000925
show subpopulations
Gnomad AFR exome
AF:
0.000278
Gnomad AMR exome
AF:
0.000163
Gnomad ASJ exome
AF:
0.000476
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00249
Gnomad NFE exome
AF:
0.00162
Gnomad OTH exome
AF:
0.00211
GnomAD4 exome
AF:
0.00149
AC:
2078
AN:
1395346
Hom.:
0
Cov.:
91
AF XY:
0.00142
AC XY:
978
AN XY:
688274
show subpopulations
African (AFR)
AF:
0.000190
AC:
6
AN:
31572
American (AMR)
AF:
0.000392
AC:
14
AN:
35702
Ashkenazi Jewish (ASJ)
AF:
0.000675
AC:
17
AN:
25174
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35734
South Asian (SAS)
AF:
0.0000379
AC:
3
AN:
79196
European-Finnish (FIN)
AF:
0.00193
AC:
89
AN:
46018
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5144
European-Non Finnish (NFE)
AF:
0.00176
AC:
1899
AN:
1078910
Other (OTH)
AF:
0.000864
AC:
50
AN:
57896
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
160
320
479
639
799
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
74
148
222
296
370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00109
AC:
166
AN:
152364
Hom.:
1
Cov.:
34
AF XY:
0.00123
AC XY:
92
AN XY:
74510
show subpopulations
African (AFR)
AF:
0.000385
AC:
16
AN:
41592
American (AMR)
AF:
0.000523
AC:
8
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00301
AC:
32
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00156
AC:
106
AN:
68028
Other (OTH)
AF:
0.00142
AC:
3
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
9
19
28
38
47
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00130
Hom.:
0
Bravo
AF:
0.000876
TwinsUK
AF:
0.00216
AC:
8
ALSPAC
AF:
0.00104
AC:
4
ExAC
AF:
0.000501
AC:
12
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
Jun 01, 2021
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 03, 2023
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

Ehlers-Danlos syndrome Uncertain:1
Jun 27, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Brittle cornea syndrome 1 Uncertain:1
Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
May 05, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: ZNF469 c.8705C>T (p.Thr2902Met) results in a non-conservative amino acid change in the encoded protein sequence. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change. The variant allele was found at a frequency of 0.00099 in 148794 control chromosomes, predominantly at a frequency of 0.0016 within the Non-Finnish European subpopulation in the gnomAD database, suggesting the variant could be benign. To our knowledge, no occurrence of c.8705C>T in individuals affected with Brittle cornea syndrome 1 and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 429662). Based on the evidence outlined above, the variant was classified as likely benign. -

Cardiovascular phenotype Benign:1
May 02, 2019
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.097
BayesDel_addAF
Benign
-0.64
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
11
DANN
Uncertain
0.98
DEOGEN2
Benign
0.020
T;.
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.025
N
LIST_S2
Benign
0.46
T;.
M_CAP
Pathogenic
0.75
D
MetaRNN
Benign
0.037
T;T
MetaSVM
Benign
-0.95
T
PhyloP100
-0.34
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-0.94
N;N
REVEL
Benign
0.033
Sift
Benign
0.036
D;D
Sift4G
Uncertain
0.033
D;D
Vest4
0.10
MVP
0.040
ClinPred
0.0045
T
GERP RS
-1.4
gMVP
0.13
Mutation Taster
=70/30
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs536725615; hg19: chr16-88502583; COSMIC: COSV71258455; API